TAKE P/B Ratio
TAKE P/B ratio. TAKE (TAKE) P/B ratio is 6.17 (High), book value per share ₹20.67 vs Healthcare average P/B of -0.3 — Very High - Significant premium, high growth expectations or speculative. For live price, earnings yield and the full fundamental profile, see TAKE stock price NSE.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
TAKE P/B Ratio — Valuation Insights & Book Value Analysis
TAKE price-to-book ratio interpretation, valuation status and historical context — current P/B 6.17 (High). Read TAKE dividend growth for the complete payout history and dividend yield track record.
- Stock appears overvalued with PB of 6.17, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 1086.5% above historical average
- Trading at premium to sector average PB of -0.3
TAKE P/B Ratio Historical Trend
TAKE annual price-to-book ratio — 4 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Browse TAKE financial statements for revenue, profit, balance sheet and cash flow data.
TAKE Historical P/B Ratio — Book Value Per Share & Year-End Price
TAKE annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 0.66 | ₹20.67 | ₹13.69 | ₹31 | Low |
| 2025 | 0.9 | ₹14.0 | ₹12.66 | ₹21 | Low |
| 2023 | 0.32 | ₹72.67 | ₹23.06 | ₹109 | Low |
| 2022 | 0.2 | ₹120.67 | ₹23.85 | ₹181 | Low |
TAKE vs Healthcare Peers — P/B Ratio Comparison
TAKE P/B 6.17 vs Healthcare average -0.3, median 0.39 — range -7.62–0.89.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Chennai Meenakshi Multis… | CMMHOSP | -7.62 | ₹27 | Low |
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -1.2 | ₹39 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.75 | ₹128 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.18 | ₹43 | Low |